Title: Methods and Compositions for Increasing RNA Interference
Patent Number: 8,865,668
Filed: Feb. 20, 2009
Lead Inventor: Romaan Raemaekers, Devgen (Syngenta)
Title: RNAi-mediated Inhibition of TNA-alpha Signaling Pathway for Treatment of Glaucoma
Patent Number: 8,865,670
Filed: Feb. 10, 2011
Lead Inventor: Jon Chatterton, Alcon
Title: RNAi-mediated Inhibition of Spleen Tyrosine Kinase-related Inflammatory Conditions
Patent Number: 8,865,671
Filed: June 30, 2011
Lead Inventor: John Yanni, Alcon
Title: Compositions and Methods for Silencing Apolipoprotein B
Patent Number: 8,865,675
Filed: May 12, 2011
Lead Inventor: James Heyes, Protiva Biotherapeutics (Tekmira Pharmaceuticals)
Title: Methods and Kits for Synthesis of siRNA Expression Cassettes
Patent Number: 8,865,676
Filed: Jan. 31, 2013
Lead Inventor: John Rossi, City of Hope
Title: iRNA Agents with Biocleavable Tethers
Patent Number: 8,865,677
Filed: March 22, 2013
Lead Inventor: Muthiah Manoharan, Alnylam Pharmaceuticals
Title: microRNA Fingerprints during Human Megakaryocytopoiesis
Patent Number: 8,865,885
Filed: June 25, 2013
Lead Inventor: Carlo Croce, Ohio State University
Title: Method for Downregulating Gene Expression in Fungi
Patent Number: 8,865,968
Filed: May 12, 2010
Lead Inventor: Marc Van De Craen, Devgen (Syngenta)